Edition:
United Kingdom

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

0.64USD
15 Nov 2018
Change (% chg)

-- (--)
Prev Close
$0.64
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
146,906
52-wk High
$2.36
52-wk Low
$0.61

Latest Key Developments (Source: Significant Developments)

Catabasis Pharmaceuticals reports third quarter financial results
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Catabasis Pharmaceuticals Inc :Catabasis Pharmaceuticals reports third quarter 2017 financial results and reviews business progress.Q3 loss per share $0.31.Q3 earnings per share view $-0.33 -- Thomson Reuters I/B/E/S.Catabasis Pharmaceuticals Inc - co's current operating plan provides for cash to fund operations through august 2018​.  Full Article